Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rapamycin”

619 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 619 results

Not applicableWithdrawnNCT01326468
What this trial is testing

Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Not applicableStudy completedNCT05198427
What this trial is testing

MTOR Inhibitors: the Lesions Induced by Papillomavirus for Transplant Patients.

Who this might be right for
Transplantation Organ
Hospices Civils de Lyon 45
Early research (Phase 1)Study completedNCT00112476
What this trial is testing

Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors

Who this might be right for
Recurrent MelanomaRecurrent Renal Cell CancerStage IV Melanoma+2 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00787969
What this trial is testing

Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 74
Testing effectiveness (Phase 2)Study completedNCT01014234
What this trial is testing

Rapamycin and Regulatory T Cells in Kidney Transplantation

Who this might be right for
Kidney Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 56
Very early researchStudy completedNCT04200911
What this trial is testing

Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

Who this might be right for
Cognitive Impairment, MildAlzheimer Disease
The University of Texas Health Science Center at San Antonio 10
Large-scale testing (Phase 3)Study completedNCT00470665
What this trial is testing

Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

Who this might be right for
Renal Allograft Recipients
Wyeth is now a wholly owned subsidiary of Pfizer 460
Testing effectiveness (Phase 2)UnknownNCT00942747
What this trial is testing

Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma

Who this might be right for
Recurrent or Refractory Primary CNS Lymphoma
Charite University, Berlin, Germany 37
Testing effectiveness (Phase 2)Study completedNCT01256385
What this trial is testing

Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Who this might be right for
Recurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more
National Cancer Institute (NCI) 86
Early research (Phase 1)Study completedNCT00563147
What this trial is testing

A Phase 1b, Open-Label, Dose-Finding Study to Evaluate the Safety of Tivozanib (AV-951) in Combination With Temsirolimus in Subjects With Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
AVEO Pharmaceuticals, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT01827267
What this trial is testing

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

Who this might be right for
HER2-mutant Non-Small Cell Lung Cancer
Puma Biotechnology, Inc. 62
Early research (Phase 1)Ended earlyNCT00337376
What this trial is testing

The mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Who this might be right for
Advanced Solid Cancers
Yale University 23
Testing effectiveness (Phase 2)Ended earlyNCT00921310
What this trial is testing

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Washington University School of Medicine 12
Early research (Phase 1)Study completedNCT00973076
What this trial is testing

Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

Who this might be right for
CancerSolid TumorsAdvanced Solid Malignancies
AstraZeneca 19
Very early researchStudy completedNCT01184885
What this trial is testing

A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

Who this might be right for
Lymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7
Early research (Phase 1)Study completedNCT03696355
What this trial is testing

Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 27
Post-approval studies (Phase 4)Study completedNCT04077515
What this trial is testing

Safety and Efficacy of Low-dose Sirolimus to Kaposiform Hemangioendothelioma

Who this might be right for
HemangiomaKaposiform Hemangioendothelioma
Children's Hospital of Fudan University 92
Early research (Phase 1)Study completedNCT00667485
What this trial is testing

Rapamycin Plus Bevacizumab in Advanced Cancers

Who this might be right for
Advanced CancerMetastatic Cancer
University of Chicago 28
Testing effectiveness (Phase 2)Study completedNCT00800917
What this trial is testing

Temsirolimus and Bevacizumab in Recurrent Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Rigshospitalet, Denmark 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT06925971
What this trial is testing

Trial of the Rapamycin Target Eluting Stent for the Treatment of Symptomatic Cerebral Artery Atherosclerotic Disease（TARGET-DREAM）

Who this might be right for
Intracranial Arteriosclerosis
MicroPort NeuroTech Co., Ltd. 279
Next Page